Search for Clinical Trial Results

Sponsored By

Peritoneal Neoplasms - 29 Studies Found

Status Study
Recruiting Study Name: An Observational Study of Avastin (Bevacizumab) in Combination With Carboplatin/Paclitaxel in First Line in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (OTILIA)
Condition: Peritoneal Neoplasms
Date: 2012-09-28
Completed Study Name: Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers
Condition: Peritoneal Neoplasms
Date: 2008-04-23
Interventions: Drug: nanoparticulate paclitaxel This is a Phase 1, dose-escalation study with 6 cohorts of 1 - 6 patien
Active, not recruiting Study Name: Quality of Life Study for Pediatric and Adult Patients Undergoing Hyperthermic Peritoneal Perfusion With Cisplatin
Condition: Peritoneal Neoplasms
Date: 2007-07-16
Interventions: Behavioral: Questionnaire QOL Questionnaires taking a total of 10 minutes to complete.
Terminated Study Name: A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis
Condition: Peritoneal Neoplasms
Date: 2006-07-14
Interventions:
  • Procedure: Surgical debulking with peritonectomy
Active, not recruiting Study Name: BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian Cancer
Condition: Ovarian Cancer, Peritoneal Neoplasms
Date: 2013-02-08
Withdrawn Study Name: Comparison of Traditional and Echocardiography Guided Fluid Management During Cytoreductive Surgery With HIPEC
Condition:
  • Peritoneal Neoplasms
  • Echocardiography Guided Fluid Management Date: 2010-07-14
    Interventions: Device: Echocardiogram Echocardiography will be utilized during the procedure to guide fluid management.
Completed Study Name: Goal Directed Therapy (GDT) in Cytoreductive Surgery (CRS) and Hyperthermic Intra Peritoneal Chemotherapy (Hipec)
Condition:
  • Primary Peritoneal Neoplasm
  • Secondary Per
    Date: 2013-06-10
    Interventions:
    • Drug: Goal Directed Intravenous Restrictive Fluid Therapy

Not yet recruiting Study Name: An Observational Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
Condition: Ovarian Cancer, Peritoneal Neoplasms
Date: 2013-08-27
Terminated Study Name: A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer
Condition:
  • Ovarian Cancer
  • Peritoneal Neoplasms

Date: 2007-08-14
Interventions: Drug: Volociximab 15 mg/kg weekly, IV infusions, for 8 weeks or until disease progression or unacceptabl
Completed Study Name: Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis
Condition:
  • Carcinoma
  • Peritoneal Neoplasm

Date: 1999-11-03
Interventions:
  • Drug: Cisplatin
  • Drug: Paclitaxel
Next >>>